Agios Pharmaceuticals | AGIO - Capitalizzazione Di Mercato





Capitalizzazione Di Mercato Cambiamento Data
AbbVie USD 359.77B 44.06B 2026-04
Agios Pharmaceuticals USD 1.53B 480M 2026-04
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amgen USD 176.25B 24.32B 2025-12
Arrowhead Research USD 9.02B 4.25B 2025-12
Astellas Pharma JPY 4.13T 430.55B 2026-04
AstraZeneca USD 212.27B 88.98B 2026-04
Bayer EUR 36.36B 9.13B 2025-12
Biogen USD 27.49B 589M 2026-04
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Daiichi Sankyo JPY 4.9T 1.44T 2026-04
Eli Lilly USD 1.02T 293.84B 2025-12
Exelixis USD 11.75B 959M 2025-12
Gilead Sciences USD 166.62B 14.34B 2026-04
GlaxoSmithKline GBP 79.5B 4.3B 2026-04
Incyte USD 21.96B 3.23B 2026-04
Ionis Pharmaceuticals USD 10.55B 1.91B 2026-04
Merck USD 261.26B 51.62B 2025-12
Nektar Therapeutics USD 14.34B 13.48B 2026-04
Novartis USD 231.75B 76B 2026-04
Novartis USD 263.08B 17.01B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Regeneron Pharmaceuticals USD 73.97B 7.71B 2026-04
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12